Key result
A 12-week aerobic dance program significantly improved walking test heart rates and times in adults with intellectual disabilities compared to controls, but benefits were lost at 18 weeks.
Why the study?
Does a 12-week low-impact aerobic dance program improve cardiovascular endurance in adults with intellectual disabilities?
Does a 12-week low-impact aerobic dance program improve cardiovascular endurance in adults with intellectual disabilities?
A 12-week aerobic dance program temporarily improves cardiovascular endurance in adults with intellectual disabilities, but the benefits are lost after exercise cessation.
May improve CVE in adults with ID; hypothesis-generating and requires RCTs before any practice change.
The purpose was to determine the effects of a 12-week, 3-days/week low-impact aerobic dance program on the cardiovascular endurance (CVE) of adults with intellectual disabilities (ID). The experimental group (8 males, 7 females) were adults ( M age = 39) receiving employment training at a sheltered workshop. The control group (7 males, 5 females) were adults ( M age = 37) affiliated with the same facility but employed offsite. Rockport Fitness Walking Test (RFWT) data were collected five times (pretest, and at 4, 8, 12, and 18 weeks). Repeated measures ANOVAs indicated that the experimental group performed significantly better than the control group on RFWT heart rates on the 8- and 12- week trials and on RFWT walk times at the posttest. Once the 12-week program was over, participants did not exercise. Follow-up measurements at 18 weeks revealed no significant differences between groups.
No takes yet. Share an insight, caveat, or question.
Cluphf et al. (2001) studied Intellectual disabilities (n=27). Low-impact aerobic dance program vs. Control group (employed offsite) was evaluated on Cardiovascular endurance (Rockport Fitness Walking Test heart rates and walk times). A 12-week aerobic dance program significantly improved walking test heart rates and times in adults with intellectual disabilities compared to controls, but benefits were lost at 18 weeks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: